Evaluation of the Effect of SURGICEL® Powder in TKA

Key facts

Sponsor

Peking University Third Hospital

Principal Investigator

Hua Tian, doctor

Director

Intervention

SURGICEL® Powder(drug)

Enrollment

112 target

Eligibility

All sexes

Timeline

2024 – 2025

Study locations (1)

• Peking University Third Hospital, Beijing, Beijing Municipality, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Microphthalmia with limb anomalies

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNANCT07478861
  Whole-body Vibration Training on the Elderly With Combined Bilateral Knee Osteoarthritis
  Beni-Suef University
• ACTIVE NOT RECRUITINGNANCT07386561
  Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty
  Wroclaw University of Health and Sport Sciences
• RECRUITINGNANCT07226973
  Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior
  Ochsner Health System
• RECRUITINGNCT07304323
  Prepare II - Predictive Model Training and External Validation
  I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
• RECRUITINGNANCT07003113
  Ischemic Preconditioning in Osteoarthritis and Back Pain
  University of Illinois at Chicago
• RECRUITINGNANCT07401719
  Effects of Modified Clamshell Exercises in Patients With Hip Osteoarthritis Grade II.
  Lahore University of Biological and Applied Sciences
• RECRUITINGPHASE2NCT06576583
  Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators.
  University Hospital, Basel, Switzerland
• RECRUITINGNCT07199751
  Comparison of Complication Rate, Functional Outcome and Quality of Life Between Standard Therapy Versus Fast-track Therapy in Patients Following Hip Replacement Surgery
  Technical University of Munich

See all trials for Microphthalmia with limb anomalies →